Hong Kong, Singapore, Shanghai, Sydney, London
Hong Kong, Singapore, Shanghai, Sydney, London
Multinational group restructurings demand absolute precision when reallocating equity interests across jurisdictions. Executing related-party equity transfers without defensible market value assessments invites aggressive scrutiny and costly transfer pricing adjustments from local tax authorities.
💡 M&A Valuation in the AI Era: More Detailed Disclosures on Valuation Judgements and Assumptions Required under Regulatory Scrutiny in Hong Kong In today’s fast-evolving market environment, Mergers and Acquisitions (M&A) remain a vital engine for corporate growth and strategic expansion. Valtech Valuation recently completed several independent asset valuation engagements for Hong Kong-listed companies
Valtech’s valuation team has recently completed a fair value assessment of biological assets for a Hong Kong listed company with livestock operation. The subject valuation was conducted for financial reporting purpose. Navigating the Complexities of Biological Transformation Unlike static corporate assets, biological assets are subject to continuous natural cycles—growth, degeneration, production, and procreation. These
Valuation underpins the pricing of shares issued to employees, partners, and early investors. ESOPs, RSUs, phantom shares, and internal share markets rely on regular, independent valuation to ensure fairness and compliance. As private companies grow and ownership structures evolve, valuation ensures incentive schemes remain grounded in economic reality.
Beyond compliance, valuation provides boards and management with deep insight into long-term value drivers. It supports capital allocation decisions, business unit performance assessment, incentive plan design, and strategic planning.
